000 02491 a2200757 4500
005 20250516031434.0
264 0 _c20110907
008 201109s 0 0 eng d
022 _a1528-0012
024 7 _a10.1053/j.gastro.2011.03.039
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChevaliez, Stéphane
245 0 0 _aHigh-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).
_h[electronic resource]
260 _bGastroenterology
_cJul 2011
300 _a119-27 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aChi-Square Distribution
650 0 4 _aDrug Resistance, Viral
_xgenetics
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHepacivirus
_xgenetics
650 0 4 _aHepatitis C, Chronic
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aInterferons
650 0 4 _aInterleukins
_xgenetics
650 0 4 _aLinear Models
650 0 4 _aLogistic Models
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOdds Ratio
650 0 4 _aPhenotype
650 0 4 _aPolyethylene Glycols
_xadministration & dosage
650 0 4 _aRNA, Viral
_xblood
650 0 4 _aRecombinant Proteins
650 0 4 _aRibavirin
_xadministration & dosage
650 0 4 _aRisk Assessment
650 0 4 _aRisk Factors
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aViral Load
700 1 _aHézode, Christophe
700 1 _aSoulier, Alexandre
700 1 _aCostes, Bruno
700 1 _aBouvier-Alias, Magali
700 1 _aRouanet, Stéphanie
700 1 _aFoucher, Juliette
700 1 _aBronowicki, Jean-Pierre
700 1 _aTran, Albert
700 1 _aRosa, Isabelle
700 1 _aMathurin, Philippe
700 1 _aAlric, Laurent
700 1 _aLeroy, Vincent
700 1 _aCouzigou, Patrice
700 1 _aMallat, Ariane
700 1 _aCharaf-Eddine, Mariem
700 1 _aBabany, Gérard
700 1 _aPawlotsky, Jean-Michel
773 0 _tGastroenterology
_gvol. 141
_gno. 1
_gp. 119-27
856 4 0 _uhttps://doi.org/10.1053/j.gastro.2011.03.039
_zAvailable from publisher's website
999 _c20709480
_d20709480